These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 34708251)

  • 21. Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin.
    Fiala M; Liu PT; Espinosa-Jeffrey A; Rosenthal MJ; Bernard G; Ringman JM; Sayre J; Zhang L; Zaghi J; Dejbakhsh S; Chiang B; Hui J; Mahanian M; Baghaee A; Hong P; Cashman J
    Proc Natl Acad Sci U S A; 2007 Jul; 104(31):12849-54. PubMed ID: 17652175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of innate immunity in Alzheimer's disease.
    Ennerfelt HE; Lukens JR
    Immunol Rev; 2020 Sep; 297(1):225-246. PubMed ID: 32588460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multi-omic comparison of Alzheimer's variants in human ESC-derived microglia reveals convergence at APOE.
    Liu T; Zhu B; Liu Y; Zhang X; Yin J; Li X; Jiang L; Hodges AP; Rosenthal SB; Zhou L; Yancey J; McQuade A; Blurton-Jones M; Tanzi RE; Huang TY; Xu H
    J Exp Med; 2020 Dec; 217(12):. PubMed ID: 32941599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune hyperreactivity of Aβ plaque-associated microglia in Alzheimer's disease.
    Yin Z; Raj D; Saiepour N; Van Dam D; Brouwer N; Holtman IR; Eggen BJL; Möller T; Tamm JA; Abdourahman A; Hol EM; Kamphuis W; Bayer TA; De Deyn PP; Boddeke E
    Neurobiol Aging; 2017 Jul; 55():115-122. PubMed ID: 28434692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune defects in Alzheimer's disease: new medications development.
    Cashman JR; Ghirmai S; Abel KJ; Fiala M
    BMC Neurosci; 2008 Dec; 9 Suppl 2(Suppl 2):S13. PubMed ID: 19090986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of late-onset Alzheimer's genetic risk factors on beta-amyloid endocytic production.
    Guimas Almeida C; Sadat Mirfakhar F; Perdigão C; Burrinha T
    Cell Mol Life Sci; 2018 Jul; 75(14):2577-2589. PubMed ID: 29704008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer's disease.
    Boza-Serrano A; Ruiz R; Sanchez-Varo R; García-Revilla J; Yang Y; Jimenez-Ferrer I; Paulus A; Wennström M; Vilalta A; Allendorf D; Davila JC; Stegmayr J; Jiménez S; Roca-Ceballos MA; Navarro-Garrido V; Swanberg M; Hsieh CL; Real LM; Englund E; Linse S; Leffler H; Nilsson UJ; Brown GC; Gutierrez A; Vitorica J; Venero JL; Deierborg T
    Acta Neuropathol; 2019 Aug; 138(2):251-273. PubMed ID: 31006066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Developing novel immunogens for a safe and effective Alzheimer's disease vaccine.
    Lemere CA
    Prog Brain Res; 2009; 175():83-93. PubMed ID: 19660650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic variants influencing human aging from late-onset Alzheimer's disease (LOAD) genome-wide association studies (GWAS).
    Shi H; Belbin O; Medway C; Brown K; Kalsheker N; Carrasquillo M; Proitsi P; Powell J; Lovestone S; Goate A; Younkin S; Passmore P; ; Morgan K;
    Neurobiol Aging; 2012 Aug; 33(8):1849.e5-18. PubMed ID: 22445811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myeloid Arginase 1 Insufficiency Exacerbates Amyloid-β Associated Neurodegenerative Pathways and Glial Signatures in a Mouse Model of Alzheimer's Disease: A Targeted Transcriptome Analysis.
    Ma C; Hunt JB; Kovalenko A; Liang H; Selenica MB; Orr MB; Zhang B; Gensel JC; Feola DJ; Gordon MN; Morgan D; Bickford PC; Lee DC
    Front Immunol; 2021; 12():628156. PubMed ID: 34046031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genome-wide association study of Alzheimer's disease.
    Kamboh MI; Demirci FY; Wang X; Minster RL; Carrasquillo MM; Pankratz VS; Younkin SG; Saykin AJ; ; Jun G; Baldwin C; Logue MW; Buros J; Farrer L; Pericak-Vance MA; Haines JL; Sweet RA; Ganguli M; Feingold E; Dekosky ST; Lopez OL; Barmada MM
    Transl Psychiatry; 2012 May; 2(5):e117. PubMed ID: 22832961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthetic amyloid beta does not induce a robust transcriptional response in innate immune cell culture systems.
    Quiroga IY; Cruikshank AE; Bond ML; Reed KSM; Evangelista BA; Tseng JH; Ragusa JV; Meeker RB; Won H; Cohen S; Cohen TJ; Phanstiel DH
    J Neuroinflammation; 2022 Apr; 19(1):99. PubMed ID: 35459147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of pathology, expression and proteomic profiles in human TREM2 variant postmortem brains with and without Alzheimer's disease.
    Toomey CE; Heywood W; Benson BC; Packham G; Mills K; Lashley T
    Brain Pathol; 2020 Jul; 30(4):794-810. PubMed ID: 32267026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Women with the Alzheimer's risk marker ApoE4 lose Aβ-specific CD4⁺ T cells 10-20 years before men.
    Begum AN; Cunha C; Sidhu H; Alkam T; Scolnick J; Rosario ER; Ethell DW
    Transl Psychiatry; 2014 Jul; 4(7):e414. PubMed ID: 25072319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integration of Alzheimer's disease genetics and myeloid genomics identifies disease risk regulatory elements and genes.
    Novikova G; Kapoor M; Tcw J; Abud EM; Efthymiou AG; Chen SX; Cheng H; Fullard JF; Bendl J; Liu Y; Roussos P; Björkegren JL; Liu Y; Poon WW; Hao K; Marcora E; Goate AM
    Nat Commun; 2021 Mar; 12(1):1610. PubMed ID: 33712570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigating APOE, APP-Aβ metabolism genes and Alzheimer's disease GWAS hits in brain small vessel ischemic disease.
    Blumenau S; Foddis M; Müller S; Holtgrewe M; Bentele K; Berchtold D; Beule D; Dirnagl U; Sassi C
    Sci Rep; 2020 Apr; 10(1):7103. PubMed ID: 32345996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ABCA7 p.G215S as potential protective factor for Alzheimer's disease.
    Sassi C; Nalls MA; Ridge PG; Gibbs JR; Ding J; Lupton MK; Troakes C; Lunnon K; Al-Sarraj S; Brown KS; Medway C; Clement N; Lord J; Turton J; Bras J; Almeida MR; ; Holstege H; Louwersheimer E; van der Flier WM; Scheltens P; Van Swieten JC; Santana I; Oliveira C; Morgan K; Powell JF; Kauwe JS; Cruchaga C; Goate AM; Singleton AB; Guerreiro R; Hardy J
    Neurobiol Aging; 2016 Oct; 46():235.e1-9. PubMed ID: 27289440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TREM2 and the neuroimmunology of Alzheimer's disease.
    Hickman SE; El Khoury J
    Biochem Pharmacol; 2014 Apr; 88(4):495-8. PubMed ID: 24355566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.